Superior outcome with direct catheter laboratory access vs ED-activated primary percutaneous coronary intervention

Bikash Majumder1, Chrysostomos Mavroudis, Colette Smith

  • 1Department of Cardiology, University Hospital Wales, Cardiff, CF14 4XW, UK. bikashmaj@hotmail.com

Insights

Directly admitting ST-elevation myocardial infarction patients to a heart attack center (HAC) catheter lab for primary percutaneous coronary intervention (PPCI) significantly reduces treatment times. This bypass of the emergency department (ED) shows improved clinical outcomes.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Health Services Research

Background:

  • ST-elevation myocardial infarction (STEMI) requires rapid reperfusion therapy.
  • Traditional STEMI treatment pathways involve the emergency department (ED) before catheterization.
  • Optimizing the STEMI treatment pathway is crucial for improving patient outcomes.

Purpose of the Study:

  • To evaluate the clinical outcomes of a redesigned primary percutaneous coronary intervention (PPCI) pathway.
  • To compare a direct heart attack center (HAC) catheter laboratory access model with the traditional ED-triggered pathway for STEMI patients.

Main Methods:

  • A retrospective analysis of 361 consecutive STEMI patients treated with PPCI.
  • Comparison of patient outcomes between direct HAC access and ED-triggered PPCI pathways.
  • Assessment of door-to-balloon times, call-to-balloon times, and composite clinical endpoints.

Main Results:

  • Direct HAC access significantly reduced door-to-balloon (39 vs. 82 minutes) and call-to-balloon (106 vs. 130 minutes) times compared to the ED pathway (P < .0001).
  • Patients in the direct HAC group showed a trend towards lower 30-day and 17-month mortality.
  • The direct HAC pathway resulted in significantly fewer composite adverse events (e.g., reduced left ventricular ejection fraction, poor myocardial perfusion) compared to the ED pathway (P = .01).

Conclusions:

  • A direct-access catheter laboratory model for PPCI, bypassing the ED, is a superior approach for STEMI treatment delivery.
  • This service redesign leads to faster treatment times and improved clinical outcomes for STEMI patients.
  • Implementing direct HAC access should be favored for optimizing STEMI care pathways.
Abstract

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...